Adolescent HIV InfectionATTACH-ScaleNCT06924073
Scale-up of an Evidence-based Adolescent Transition Package to Support Transitional Care Among Youth Living With HIV
A study testing ATP-Youth Enhanced Strategy (ATP-YES) in people with Adolescent HIV Infection and Transition to Adult Care, run by University of Washington at 25 sites in Kenya.
Trial summary
Ending the HIV epidemic for youth living with HIV will require implementation and optimization of evidence-based interventions that address barriers to treatment. The proposed implementation study will test a youth-led data-driven implementation strategy to scale-up an evidence-based Adolescent Transition Package… Read more about this study
- Who is it for?
- Ages 10 years and olderHealthy volunteers can take part
- Conditions the study is for
- Adolescent HIV Infection, Transition to Adult Care, Implementation Science
- What is being tested?
- ATP-Youth Enhanced Strategy (ATP-YES)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,920 participants
- Where
- 25 sitesKenya
- Study dates
- 16 Oct 2025to 30 Jan 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Healthcare providers
- ≥18 years of age
- Employed at one of the 32 facilities in the RCT
- Provides HIV services to adolescents affiliated within their clinic Adolescents and youth living with HIV
- Between 15-24 years of age (focus group discussions, surveys) or between 10-24 years of age (offered the intervention)
- Receives HIV clinical care at one of the clinics included in the study
- Attended clinic ≥1 time following intervention implementation
Who cannot join
- Any individual who meets the following criteria will be excluded from participation in this study:
- Conditions that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study
Trial locations and contacts
25 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Irene Njuguna, MBChB, MPH, PhD contact
25 sites in 1 country
Kenya25 sites, 25 recruiting
- Recruiting
Awendo Sub County Hospital
Awendo
Medical Supervisor, 254-723227477, mnn3@uw.edu
- Recruiting
Uriri Sub County Hospital
Awendo
Medical Supervisor, 254-701969623, mnn3@uw.edu
- Recruiting
Gatundu Level 5 Hospital
Gatundu
Medical Supervisor, 254-723600862, gatundul4h@gmail.com
- Recruiting
Kiambu County Referral Hospital
Kiambu
Medical Supervisor, 254-723273546, kiambudistricthospital@gmail.com
- Recruiting
Wangige Sub-County Hospital
Kiambu
Medical Supervisor, 254-723243427, mnn3@uw.edu
- Recruiting
Kikuyu (PCEA) Hospital
Kikuyu
Medical Supervisor, 254-720921267, cmo@pceakikuyuhospital.org
- Recruiting
Nazareth Hospital
Limuru
Medical Supervisor, 254-722405166, Info@nazarethhospital.or.ke
- Recruiting
Arombe Dispensary
Migori
Medical Supervisor, 254-797603497, mnn3@uw.edu
- Recruiting
Dede Health Centre
Migori
Medical Supervisor, 254-727629677, mnn3@uw.edu
- Recruiting
Migori County Referral Hospital
Migori
Medical Supervisor, 254-794456890, mnn3@uw.edu
- Recruiting
St Joseph Mission Hospital (Ombo)
Migori
Medical Supervisor, 254-723628148, mnn3@uw.edu
- Recruiting
Baraka Dispensary (Nairobi)
Nairobi
Medical Supervisor, 254-711639234, mnn3@uw.edu
- Recruiting
Embakasi Health Centre
Nairobi
Medical Supervisor, 254-202318794, mnn3@uw.edu
- Not yet recruiting
Kenyatta National Hospital/University of Nairobi
Nairobi
Teresiah N Maina, +254-020-723-448-552, trenjambs@gmail.com
Dalton Wamalwa, dalton.wamalwa@uonbi.ac.ke
- Recruiting
Mama Lucy Kibaki Hospital
Nairobi
Medical Supervisor, 254-208022676, medsupnedh@yahoo.com
- Recruiting
Mbagathi District Hospital
Nairobi
Medical Supervisor, 254-202724712, mbagathihosp@gmail.com
- Recruiting
Mukuru Health Centre
Nairobi
Medical Supervisor, 254-710802246, mnn3@uw.edu
- Recruiting
Pumwani Maternity Hospital
Nairobi
Medical Supervisor, 254-778564272, pumwanimaternityhospital@gmail.com
- Recruiting
Tabitha Medical Clinic
Nairobi
Medical Supervisor, 254-725407044, joy.barnice@cfkafrica.org
- Recruiting
Umoja Health Center
Nairobi
Medical Supervisor, 254-710628919, mnn3@uw.edu
- Recruiting
Rongo Sub County Hospital
Rongo
Medical Supervisor, 254-713463946, mnn3@uw.edu
- Recruiting
Verna Health Centre
Rongo
Medical Supervisor, 254-705574747, mnn3@uw.edu
- Recruiting
Ruiru Sub-County Hospital
Ruiru
Medical Supervisor, 254-714799080, wanjirupatience35@gmail.com
- Recruiting
Kiandutu Health Centre
Thika
Medical Supervisor, 254-720311498, mnn3@uw.edu
- Recruiting
Thika Level 5 Hospital
Thika
Medical Supervisor, 254-723884069, alengawek@gmail.com
About this study
Ending the HIV epidemic for youth living with HIV will require implementation and optimization of evidence-based interventions that address barriers to treatment. The proposed implementation study will test a youth-led data-driven implementation strategy to scale-up an evidence-based Adolescent Transition Package (ATP) aimed at improving transition processes and post-transition clinical outcomes for youth living with HIV in Kenya. Clinics will be randomized to receive standard of care implementation through trainer of trainers or the youth-led data-driven implementation strategy alongside trainer of trainers. We will study whether the enhanced implementation strategy improves the number of youth who receive the ATP, the number of providers that initially chose to use the ATP, and the consistency with which the ATP is used over time. We will also evaluate the cost of the ATP and whether the ATP improves health outcomes among youth living with HIV, including viral suppression and retention in care. Healthcare workers at study sites will complete surveys, focus group discussions, interviews, and participate in continuous quality improvement processes. Youth will participate in surveys and focus groups, and have their routine medical records abstracted.
Read the detailed description
The proposed project extends the team's previously conducted cluster randomized controlled trial, the Adolescent Transition to Adult Care (ATTACH) study (NIH R01HD089850-01; PI John-Stewart). This new R01 tests an implementation strategy to improve scale up of an Adolescent Transition Package (ATP), developed during the previous clinical trial, within health facilities in Kenya and evaluate the cost-effectiveness and budget impact of the implementation strategy. Primary outcomes include measuring intervention uptake and delivery outcomes using the Reach, Effectiveness, Adoption, Implementation and Maintenance (RE-AIM) framework, factors influencing implementation, clinical outcomes, and cost.
The ATP is a healthcare worker (HCW) delivered toolkit that supports the transition from pediatric to independent care for youth living with HIV (YLH). The ATP was developed by the ATTACH study, working in partnership with the Kenya Ministry of Health and other key collaborators leading treatment and care provision in Kenya. The ATP is designed to support transition to adult care for YLH and provide YLH with the knowledge and skills needed to independently manage HIV. The ATP combined two evidence-based interventions from other contexts (Namibia and the United States) and adapted them to better meet Kenyan patient, provider and health system needs. The ATP was tested in a randomized controlled trial of 20 clinics in 4 counties in Kenya (ATTACH study), and shown to significantly improve readiness to transition among YLH in intervention sites compared to those in the control. HCWs and YLH appreciated the content and design of the ATP as they found it feasible and acceptable for routine clinic use.
During this scale up focused R01, the ATP will be administered at the clinic level by existing HCWs during routine YLH clinic visits, as in the original trial. In all participating clinics, all eligible adolescents aged 10-24 years will have medical record data abstracted, and older YLH (ages 15-24) will be offered the opportunity to participate in surveys and qualitative data collection. HCWs from participating clinics will provide feedback on implementation throughout the study and work to optimize delivery of the ATP within their clinic settings.
The ATTACH-Scale study includes implementation of the ATP in 32 clinics. The 32 study sites for this R01 will be selected from a large list of eligible facilities, and specific clinics will be selected by prioritizing high HIV volume clinics (>50 YLH per clinic), existing collaborations (ex: ATTACH study sites), and MoH priorities. Selection of intervention and control sites will be done using stratified randomization, balancing for county and model of HIV care in the clinic, by a biostatistician based at the University of Washington. The units of analysis vary by study aim, and are either at the level of the HCW, YLH, or clinic, depending on the specific aim and outcome being assessed.
Specific details for each study aim are described below.
Aim 1 (SCALE-UP): Using an effectiveness-implementation hybrid III design, the study will test the impact of ATP scale-up using the Kenya MoH standard of care (SoC) implementation strategy (Trainer of Trainers [ToT]) versus an enhanced scale-up implementation strategy that includes the SoC plus youth-led data- driven intervention adaptations (ATP-YES). ATP-YES is a multi-component youth led package that incorporates weekly data assessments, data review and adaptation meetings, and cross collaborative learning across intervention sites. In total, 32 HIV clinics (4 counties, 8 per county) will be randomized 1:1 to 36 months of ATP-YES or SoC alone. The Reach, Effectiveness, Adoption, Implementation and Maintenance [RE-AIM] framework will be used to evaluate and compare ATP implementation and guide real-time ATP adaptations. Specifically, ATP reach (YLH exposed to ATP), effectiveness (intervention effect on transition readiness, viral suppression and retention), adoption (proportion of HCWs implementing the ATP), implementation (fidelity to ATP processes), and maintenance (continued use post-trial) will be measured at each study site and compared between intervention and control arms. The Consolidated Framework for Implementation Research (CFIR) will be used to understand the role of context on how and why the ATP-YES strategy is or is not successful. The Framework for Reporting Adaptations and Modifications to Evidence-based Implementation Strategies (FRAME-IS) will be used to systematically study adaptations to the ATP and ATP-YES implementation strategy.
Aim 2 (COSTING): Simultaneously with Aim 1, program costs will be captured and the budget impact of ATP-YES will be compared between intervention and control sites. Micro costing, involving HCW interviews and time and motion observations, will be used to estimate the incremental costs of implementing the ATP-YES strategy and develop a model to project the health impact (HIV deaths and morbidity averted) and financial costs of ATP-YES compared to SoC.
Impact: The study will determine whether the ATP-YES can be used to effectively and affordably support implementation of the ATP in Kenya. The study team hypothesizes that this implementation strategy will improve uptake, integration, and delivery of the ATP within existing YLH clinics.
Alongside study aims, this project will engage communities, build capacity for IS research among youth, program implementers and policy-makers, and participate in collaborative science. The project includes collaboration with MOH in Kenya to ensure transition tools and implementation processes align with and integrate MOH priorities and strategies. The study also includes creation of a youth advisory board and engagement of policy-makers, HCWs, program implementers and other key stakeholders throughout the entirety of the study. Finally, the study supports youth to gain research skills and build capacity for conducting research through their leadership roles in ATP-YES, involvement in youth mentorship programs, and the youth advisory board.
- Conditions
- Adolescent HIV Infection, Transition to Adult Care, Implementation Science, Implementation Strategies
- Being tested
- ATP-Youth Enhanced Strategy (ATP-YES)
- Keywords
- Adolescent HIV, Transition to Adult Care, Scale-up, Implementation science, implementation strategy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ATP-Youth Enhanced Strategy (ATP-YES)Other
ATP-YES is a multi-component youth led implementation strategy that incorporates data audits and feedback, cyclical small tests of change and learning collaboratives
| Study group | Role | What they receive |
|---|---|---|
| Training of trainers | No intervention | Sites assigned to the standard of care (SoC) control arm will receive cascading training of trainers (ToTs) and cascade training to sites for supporting scale-up of the ATP |
| Youth Enhanced Implementation Strategy (ATP-YES) | Experimental | Sites assigned to the intervention arm will receive the ATP-YES implementation strategy, a multi-component youth led implementation strategy that incorporates data audits and feedback, cyclical small tests of change and learning collaboratives, to support scale-up of the ATP Receives: Other: ATP-Youth Enhanced Strategy (ATP-YES) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Reach
Proportion of youth living with HIV ages 15-24 years exposed to the ATP intervention
Measured: From enrollment through 6 months post study end (42 months)
Effectiveness: Successful Transfer
Proportion of youth living with HIV who attend first adult clinic visit
Measured: From enrollment through 6 months post study end (42 months)
Effectiveness: Retention
Number of scheduled clinic visits youth living with HIV attend in the year after transition to adult care
Measured: From enrollment through 6 months post study end (42 months)
Adoption
Proportion of health providers in youth HIV clinics who deliver the ATP
Measured: From enrollment through 6 months post study end (42 months)
Secondary outcomes (5)
Effectiveness: Transition Readiness
Change in transition readiness scores
Measured: From enrollment through 6 months post study end (42 months)
Effectiveness: Viral Suppression
Proportion of youth living with HIV who are virally suppressed 12 months after transition to adult clinics
Measured: From enrollment through 6 months post study end (42 months)
Implementation: Fidelity to ATP
Proportion of facilities that deliver the ATP as designed
Measured: From enrollment through 6 months post study end (42 months)
Implementation: Fidelity to ATP-YES
Proportion of facilities that deliver the ATP-YES as designed in intervention clinics
Measured: From enrollment through 6 months post study end (42 months)
Maintenance
Proportion of clinics that continue use the ATP as designed 6 months post study
Measured: From study end (36 months) through 6 months post study end (42 months)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Apr 2025
- Study start16 Oct 2025
- Primary completion30 Jan 2029 (estimated)
- Study completion30 Jan 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Adolescent HIV InfectionStudies of the same condition, open and under way.
- More trials run by University of WashingtonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 1,920 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Washington
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH), Kenyatta National Hospital, University of Nairobi, Kenya
- Responsible party
- Principal investigator, Kristin Beima-Sofie, University of Washington
- Investigators
- Kristin M Beima-Sofie, PhD, MPH, Principal investigator, University of WashingtonIrene Njuguna, MBChB, MPH, PhD, Principal investigator, Kenyatta National HospitalGrace John-Stewart, MD, PhD, MPH, Principal investigator, University of WashingtonDalton Wamalwa, MBChB, MMed, MPH, Principal investigator, University of Nairobi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06924073
- Sponsor's protocol ID
- STUDY00020373
- Other IDs
- 1R01MH136897
- Acronym
- ATTACH-Scale
- Status last verified
- Nov 2025
- First submitted
- 4 Apr 2025
- Last updated
- 14 Nov 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The research community will have access to data when the award ends. De-identified individual and aggregate survey data (including raw and recoded data) will be deposited to NDA starting 12 months after the award begins and will be deposited every six months thereafter following the usual NDA data submission dates. As required by NDA, studies will also be created that contain the data used for every publication. Documentation to be made publicly available to the research community will include PDF, Word, and Excel documents containing survey instruments, interview guides, data collection protocols, codebooks for surveys and qualitative analysis, and code used in survey data analyses. Abstracted medical records will be used as secondary data and will not be shared. Transcripts from focus group discussions and interviews with providers, and voice recordings of focus groups or interviews from youth and providers will not be shared to protect participant privacy.
Study at a glance
From the registry record, last updated by the sponsor on 14 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Scale-up of an Evidence-based Adolescent Transition Package to Support Transitional Care Among Youth Living With HIV
- ClinicalTrials.gov ID
- NCT06924073
- Acronym / sponsor ID
- ATTACH-Scale / STUDY00020373
- Conditions
- Adolescent HIV Infection, Transition to Adult Care, Implementation Science, Implementation Strategies
- Keywords
- Adolescent HIV, Transition to Adult Care, Scale-up, Implementation science, implementation strategy
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 1,920 participants (estimated)
- Lead sponsor
- University of WashingtonUniversity, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH), Kenyatta National Hospital, University of Nairobi, Kenya
- Study start
- 16 Oct 2025 (actual)
- Primary completion
- 30 Jan 2029 (estimated)
- Study completion
- 30 Jan 2029 (estimated)
- First posted
- 11 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Ending the HIV epidemic for youth living with HIV will require implementation and optimization of evidence-based interventions that address barriers to treatment. The proposed implementation study will test a youth-led data-driven implementation strategy to scale-up an evidence-based Adolescent Transition Package (ATP) aimed at improving transition processes and post-transition clinical outcomes for youth living with HIV in Kenya. Clinics will be randomized to receive standard of care implementation through trainer of trainers or the youth-led data-driven implementation strategy alongside trainer of trainers. We will study whether the enhanced implementation strategy improves the number of youth who receive the ATP, the number of providers that initially chose to use the ATP, and the consistency with which the ATP is used over time. We will also evaluate the cost of the ATP and whether the ATP improves health outcomes among youth living with HIV, including viral suppression and retention in care. Healthcare workers at study sites will complete surveys, focus group discussions, interviews, and participate in continuous quality improvement processes. Youth will participate in surveys and focus groups, and have their routine medical records abstracted.
Detailed description
The proposed project extends the team's previously conducted cluster randomized controlled trial, the Adolescent Transition to Adult Care (ATTACH) study (NIH R01HD089850-01; PI John-Stewart). This new R01 tests an implementation strategy to improve scale up of an Adolescent Transition Package (ATP), developed during the previous clinical trial, within health facilities in Kenya and evaluate the cost-effectiveness and budget impact of the implementation strategy. Primary outcomes include measuring intervention uptake and delivery outcomes using the Reach, Effectiveness, Adoption, Implementation and Maintenance (RE-AIM) framework, factors influencing implementation, clinical outcomes, and cost.
The ATP is a healthcare worker (HCW) delivered toolkit that supports the transition from pediatric to independent care for youth living with HIV (YLH). The ATP was developed by the ATTACH study, working in partnership with the Kenya Ministry of Health and other key collaborators leading treatment and care provision in Kenya. The ATP is designed to support transition to adult care for YLH and provide YLH with the knowledge and skills needed to independently manage HIV. The ATP combined two evidence-based interventions from other contexts (Namibia and the United States) and adapted them to better meet Kenyan patient, provider and health system needs. The ATP was tested in a randomized controlled trial of 20 clinics in 4 counties in Kenya (ATTACH study), and shown to significantly improve readiness to transition among YLH in intervention sites compared to those in the control. HCWs and YLH appreciated the content and design of the ATP as they found it feasible and acceptable for routine clinic use.
During this scale up focused R01, the ATP will be administered at the clinic level by existing HCWs during routine YLH clinic visits, as in the original trial. In all participating clinics, all eligible adolescents aged 10-24 years will have medical record data abstracted, and older YLH (ages 15-24) will be offered the opportunity to participate in surveys and qualitative data collection. HCWs from participating clinics will provide feedback on implementation throughout the study and work to optimize delivery of the ATP within their clinic settings.
The ATTACH-Scale study includes implementation of the ATP in 32 clinics. The 32 study sites for this R01 will be selected from a large list of eligible facilities, and specific clinics will be selected by prioritizing high HIV volume clinics (>50 YLH per clinic), existing collaborations (ex: ATTACH study sites), and MoH priorities. Selection of intervention and control sites will be done using stratified randomization, balancing for county and model of HIV care in the clinic, by a biostatistician based at the University of Washington. The units of analysis vary by study aim, and are either at the level of the HCW, YLH, or clinic, depending on the specific aim and outcome being assessed.
Specific details for each study aim are described below.
Aim 1 (SCALE-UP): Using an effectiveness-implementation hybrid III design, the study will test the impact of ATP scale-up using the Kenya MoH standard of care (SoC) implementation strategy (Trainer of Trainers [ToT]) versus an enhanced scale-up implementation strategy that includes the SoC plus youth-led data- driven intervention adaptations (ATP-YES). ATP-YES is a multi-component youth led package that incorporates weekly data assessments, data review and adaptation meetings, and cross collaborative learning across intervention sites. In total, 32 HIV clinics (4 counties, 8 per county) will be randomized 1:1 to 36 months of ATP-YES or SoC alone. The Reach, Effectiveness, Adoption, Implementation and Maintenance [RE-AIM] framework will be used to evaluate and compare ATP implementation and guide real-time ATP adaptations. Specifically, ATP reach (YLH exposed to ATP), effectiveness (intervention effect on transition readiness, viral suppression and retention), adoption (proportion of HCWs implementing the ATP), implementation (fidelity to ATP processes), and maintenance (continued use post-trial) will be measured at each study site and compared between intervention and control arms. The Consolidated Framework for Implementation Research (CFIR) will be used to understand the role of context on how and why the ATP-YES strategy is or is not successful. The Framework for Reporting Adaptations and Modifications to Evidence-based Implementation Strategies (FRAME-IS) will be used to systematically study adaptations to the ATP and ATP-YES implementation strategy.
Aim 2 (COSTING): Simultaneously with Aim 1, program costs will be captured and the budget impact of ATP-YES will be compared between intervention and control sites. Micro costing, involving HCW interviews and time and motion observations, will be used to estimate the incremental costs of implementing the ATP-YES strategy and develop a model to project the health impact (HIV deaths and morbidity averted) and financial costs of ATP-YES compared to SoC.
Impact: The study will determine whether the ATP-YES can be used to effectively and affordably support implementation of the ATP in Kenya. The study team hypothesizes that this implementation strategy will improve uptake, integration, and delivery of the ATP within existing YLH clinics.
Alongside study aims, this project will engage communities, build capacity for IS research among youth, program implementers and policy-makers, and participate in collaborative science. The project includes collaboration with MOH in Kenya to ensure transition tools and implementation processes align with and integrate MOH priorities and strategies. The study also includes creation of a youth advisory board and engagement of policy-makers, HCWs, program implementers and other key stakeholders throughout the entirety of the study. Finally, the study supports youth to gain research skills and build capacity for conducting research through their leadership roles in ATP-YES, involvement in youth mentorship programs, and the youth advisory board.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Training of trainers | No intervention | –Sites assigned to the standard of care (SoC) control arm will receive cascading training of trainers (ToTs) and cascade training to sites for supporting scale-up of the ATP |
| Youth Enhanced Implementation Strategy (ATP-YES) | Experimental | Other: ATP-Youth Enhanced Strategy (ATP-YES)Sites assigned to the intervention arm will receive the ATP-YES implementation strategy, a multi-component youth led implementation strategy that incorporates data audits and feedback, cyclical small tests of change and learning collaboratives, to support scale-up of the ATP |
Who may qualify
- Ages
- 10 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (7 listed)
- Healthcare providers
- ≥18 years of age
- Employed at one of the 32 facilities in the RCT
- Provides HIV services to adolescents affiliated within their clinic Adolescents and youth living with HIV
- Between 15-24 years of age (focus group discussions, surveys) or between 10-24 years of age (offered the intervention)
Key exclusion criteria (2 listed)
- Any individual who meets the following criteria will be excluded from participation in this study:
- Conditions that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ATP-Youth Enhanced Strategy (ATP-YES)ATP-YES is a multi-component youth led implementation strategy that incorporates data audits and feedback, cyclical small tests of change and learning collaboratives | Other | Youth Enhanced Implementation Strategy (ATP-YES) |
Primary outcome
Reach
Time frame: From enrollment through 6 months post study end (42 months)
Proportion of youth living with HIV ages 15-24 years exposed to the ATP intervention
Effectiveness: Successful Transfer
Time frame: From enrollment through 6 months post study end (42 months)
Proportion of youth living with HIV who attend first adult clinic visit
Effectiveness: Retention
Time frame: From enrollment through 6 months post study end (42 months)
Number of scheduled clinic visits youth living with HIV attend in the year after transition to adult care
Adoption
Time frame: From enrollment through 6 months post study end (42 months)
Proportion of health providers in youth HIV clinics who deliver the ATP
5 secondary outcomes
Effectiveness: Transition Readiness
Time frame: From enrollment through 6 months post study end (42 months)
Effectiveness: Viral Suppression
Time frame: From enrollment through 6 months post study end (42 months)
Implementation: Fidelity to ATP
Time frame: From enrollment through 6 months post study end (42 months)
Implementation: Fidelity to ATP-YES
Time frame: From enrollment through 6 months post study end (42 months)
Maintenance
Time frame: From study end (36 months) through 6 months post study end (42 months)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Nov 2025.
- Individual participant dataSharing planned: Yes. The research community will have access to data when the award ends. De-identified individual and aggregate survey data (including raw and recoded data) will be deposited to NDA starting 12 months after the award begins and will be deposited every six months thereafter following the usual NDA data submission dates. As required by NDA, studies will also be created that contain the data used for every publication. Documentation to be made publicly available to the research community will include PDF, Word, and Excel documents containing survey instruments, interview guides, data collection protocols, codebooks for surveys and qualitative analysis, and code used in survey data analyses. Abstracted medical records will be used as secondary data and will not be shared. Transcripts from focus group discussions and interviews with providers, and voice recordings of focus groups or interviews from youth and providers will not be shared to protect participant privacy.
Related trials for Adolescent HIV Infection
RecruitingPhase 4
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
HIV-1-infection
Not yet recruiting
HC-HMP: Healthy Choices Implementation Trial
Alcohol Drinking, HIV Infections
Recruiting
AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
Cervical Cancer, Kaposi Sarcoma
Recruiting
Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
HIV
Not yet recruiting
PNF RCT to Decrease Alcohol Use and Increase HIV Prevention
HIV (Human Immunodeficiency Virus), Alcohol Misuse
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Irene Njuguna, MBChB, MPH, PhD contact
Kristin M Beima-Sofie, PhD, MPH principal investigator
University of Washington
Irene Njuguna, MBChB, MPH, PhD principal investigator
Kenyatta National Hospital
Grace John-Stewart, MD, PhD, MPH principal investigator
University of Washington
25 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ATP-Youth Enhanced Strategy (ATP-YES) in people with Adolescent HIV Infection and Transition to Adult Care, run by University of Washington at 25 sites in Kenya.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 25 sites in Kenya. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Kristin M Beima-Sofie, PhD, MPH (206-685-8332, beimak@uw.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reach (time frame: From enrollment through 6 months post study end (42 months)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2025.